Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAINLESS NGF CHF6467 for optic pathway glioma
2020-005264-60Phase 2Active
- Sponsor
- Policlinico Gemelli
- Start
- Jun 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of CHF6467 in optic nerve glioma (OPG) (2 arms), sponsored by Policlinico Gemelli. Primary endpoint: Visual field radius by Goldmann kinetic perimetry. Started Jun 2021; status: active.
02
Drugs
CHF6467
03
Conditions
optic nerve glioma (OPG)
Beyond the preview
Go deeper on 2020-005264-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005264-60.